Results 41 to 50 of about 8,269 (177)

Malignant Craniopharyngioma

open access: yesArchives of Pathology & Laboratory Medicine, 1999
Abstract Craniopharyngiomas are histologically and cytologically benign epithelial tumors of the central nervous system that may be locally aggressive and tend to recur after excision. Malignant change in craniopharyngiomas is extremely rare; we found only 4 such reports in the literature.
T, Kristopaitis   +3 more
openaire   +2 more sources

Understanding the Symptom Burden of Complex Skull Base Tumors From the Patient's Perspective

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Symptom burden of skull base tumor (SBT) patients, especially those undergoing multimodality treatment, is poorly understood. We aim to understand symptom burden in this patient group using the core module the MD Anderson Symptom Inventory (MDASI).
Shirley Y. Su   +8 more
wiley   +1 more source

Craniopharyngioma: A comprehensive review of the clinical presentation, radiological findings, management, and future Perspective

open access: yesHeliyon
Craniopharyngioma (CP) is a rare intracranial tumor arising from the epithelial remnants of Rathke's pouch, most frequently originating in the sellar/parasellar region.
Maryam Nashi Alboqami   +9 more
doaj   +1 more source

Development and validation of a nutrition risk screening for patients with childhood cancer in Brazil (NUTRICCAN)

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background Diagnosing malnutrition in patients with pediatric cancer is challenging because tumor masses can interfere with anthropometric measurements. STRONGkids considers cancer a general risk factor, whereas Screening Tool for Childhood Cancer (SCAN) classifies patients as at risk or not, potentially missing those who need nutrition ...
Cristiane Ferreira Marçon   +2 more
wiley   +1 more source

Craniopharyngioma in Adults [PDF]

open access: yesFrontiers in Endocrinology, 2012
Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overall incidence rate of approximately 1.3 per million. During adulthood there is a peak incidence between 40 and 44 years. There are two histopathological types, the adamantinomatous and the papillary type.
Zoicas, Flavius, Schöfl, Christof
openaire   +3 more sources

Voluminous craniopharyngioma evolving since childhood revealed by a torticollis

open access: yesJournal of Family Medicine and Primary Care, 2022
In case of a torticollis or a stature-weight growth delay in a child, it is always necessary to eliminate a cerebral tumor in the first place, especially a craniopharyngioma.
Ikram Damoune   +2 more
doaj   +1 more source

Malignant craniopharyngiomas: Institutional experience and literature review

open access: yesBrain Pathology, EarlyView.
We report the second case of malignant craniopharyngioma with BAP1 and TP53 mutations. A literature review identified 44 cases of malignant craniopharyngiomas with a median overall survival of 6 months. Eighteen (41%) occurred in patients without any history of radiation, suggesting that mechanisms other than radiation have contributed to their ...
Thomas J. Auen   +10 more
wiley   +1 more source

Hypopituitarism as a result of recurrent craniopharyngioma

open access: yesМедицинский вестник Юга России, 2020
The article presents a clinical observation of a patient with a complication of endoscopic endonasal removal of craniopharyngioma in the form of hypopituitarism.
Z. R. Alimetova, A. I. Galieva
doaj   +1 more source

Cancer pain: current practice and emerging targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye   +5 more
wiley   +1 more source

Insights into body composition in pediatric craniopharyngioma patients after surgical treatment

open access: yesTherapeutic Advances in Endocrinology and Metabolism
Background: Craniopharyngioma, a benign suprasellar tumor, is typically treated surgically with radiotherapy when indicated. Due to its proximity to the pituitary-hypothalamic region, patients often experience endocrine deficiencies.
Hussein Zaitoon   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy